COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00862394
Recruitment Status : Completed
First Posted : March 16, 2009
Last Update Posted : April 13, 2018
Information provided by (Responsible Party):
Chiesi Farmaceutici S.p.A.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2009
Actual Study Completion Date : January 2010